NCCN Chemotherapy Order Templates (NCCN Templates) Reviewer Acknowledgement

The NCCN Templates® reviewers play a critical role in the development and maintenance of the NCCN Templates. NCCN Templates reviewers consist of physicians, pharmacists, and nurses from NCCN Member Institutions. They were selected based on their clinical expertise with regard to systemic therapies as well as disease-specific subspecialty areas. NCCN Template content is reviewed annually based on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), the NCCN Drugs & Biologics Compendium (NCCN Compendium®), published drug information and research, and clinical experience. NCCN would like to recognize and thank the following volunteer reviewers for contributing their time and expertise:

Acute Lymphoblastic Leukemia

  • Ila M. Saunders, PharmD, BCOP
    UC San Diego Moores Cancer Center

  • Bijal Shah, MD
    Moffitt Cancer Center

  • Michael Styler, MD
    Fox Chase Cancer Center

  • James Thompson, MD, MS
    Roswell Park Comprehensive Cancer Center

Acute Myeloid Leukemia

  • Deborah McCue, PharmD, BCOP
    The University of Texas MD Anderson Cancer Center

  • Alice S. Mims, MD, MS
    The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute

  • James Thompson, MD, MS
    Roswell Park Comprehensive Cancer Center

Anal Carcinoma

  • Sally Barbour, PharmD, CPP, BCOP, FHOPA
    Duke Cancer Institute

  • Stacey A. Cohen, MD
    Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

  • Eve M. Segal, PharmD, BCOP
    Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

B-Cell Lymphomas

  • Julio C. Chavez, MD
    Moffitt Cancer Center

  • Martina Fraga, PharmD
    University of Michigan Rogel Cancer Center

  • Thomas M. Habermann, MD
    Mayo Clinic Cancer Center

  • Francisco J. Hernandez-Ilizaliturri, MD
    Roswell Park Comprehensive Cancer Center

  • Mitchell E. Hughes, PharmD, BCOP
    Abramson Cancer Center at the University of Pennsylvania

  • Ann S. LaCasce, MD
    Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center

  • Kristen B. McCullough, PharmD, RPh
    Mayo Clinic Cancer Center

  • Ariela Noy, MD
    Memorial Sloan Kettering Cancer Center

  • Samantha Price, PharmD, BCOP
    Moffitt Cancer Center

  • Ila M. Saunders, PharmD, BCOP
    UC San Diego Moores Cancer Center

  • Shayna A. Simon, PharmD, BCOP
    UT Southwestern Simmons Comprehensive Cancer Center

  • Stephen D. Smith, MD
    Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

  • Michael Styler, MD
    Fox Chase Cancer Center

  • Katie Tobon, PharmD, BCOP
    Moffitt Cancer Center

Bladder Cancer

  • Alan Chin, PharmD, BCOP
    UCSF Helen Diller Family Comprehensive Cancer Center

  • Arlene O. Siefker-Radtke, MD
    The University of Texas MD Anderson Cancer Center

  • Philippe E. Spiess, MD, MS
    Moffitt Cancer Center

Breast Cancer

  • Anthony D. Elias, MD
    University of Colorado Cancer Center

  • Kristin Leonardi-Warren, ND, RN, CNS
    University of Colorado Cancer Center

  • Karen Lisa Smith, MD, MPH
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

  • John H. Ward, MD
    Huntsman Cancer Institute at the University of Utah

  • Robert Wesolowski, MD
    The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute

Central Nervous System Cancers

  • Sally Barbour, PharmD, CPP, BCOP, FHOPA
    Duke Cancer Institute

  • Peter Forsyth, MD
    Moffitt Cancer Center

  • Mitchell E. Hughes, PharmD, BCOP
    Abramson Cancer Center at the University of Pennsylvania

  • Mary S. Mably, RPh, BCOP
    University of Wisconsin Carbone Cancer Center

  • Seema Nagpal, MD
    Stanford Cancer Institute

  • Katherine B. Peters, MD, PhD, FAAN
    Duke Cancer Institute

Cervical Cancer

  • Nadeem R. Abu-Rustum, MD
    Memorial Sloan Kettering Cancer Center

  • Marta Ann Crispens, MD
    Vanderbilt-Ingram Cancer Center

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

  • Scott Huntington, MD, MPH, MSHP
    Yale Cancer Center/Smilow Cancer Hospital

Colon Cancer

  • Sally Barbour, PharmD, CPP, BCOP, FHOPA
    Duke Cancer Institute

  • Alan Chin, PharmD, BCOP
    UCSF Helen Diller Family Comprehensive Cancer Center

  • Stacey A. Cohen, MD
    Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

Esophageal and Esophagogastric Junction Cancers

  • Heidi D. Finnes, PharmD, BCOP
    Mayo Clinic Cancer Center

  • Michael Gibson, MD, PhD, FACP
    Vanderbilt-Ingram Cancer Center

  • Samuel J. Klempner, MD
    Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center

  • Haeseong Park, MD, MPH
    Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

  • Eve M. Segal, PharmD, BCOP
    Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

  • Lindsey Zinck, MSN, RN, OCN
    Abramson Cancer Center at the University of Pennsylvania

Gastric Cancer

  • Courtney C. Cavalieri, PharmD, BCOP
    Huntsman Cancer Institute at the University of Utah

  • Heidi D. Finnes, PharmD, BCOP
    Mayo Clinic Cancer Center

  • Michael Gibson, MD, PhD, FACP
    Vanderbilt-Ingram Cancer Center

  • Samuel J. Klempner, MD
    Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center

  • Haeseong Park, MD, MPH
    Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

  • Eve M. Segal, PharmD, BCOP
    Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

  • Lindsey Zinck, MSN, RN, OCN
    Abramson Cancer Center at the University of Pennsylvania

Gastrointestinal Stromal Tumors (GIST)

  • Kristen N. Ganjoo, MD
    Stanford Cancer Institute

  • Daniel Melzer, PharmD, BCOP
    Moffitt Cancer Center

Gestational Trophoblastic Neoplasia

  • Christina S. Chu, MD
    Fox Chase Cancer Center

  • Elisabeth J. Diver, MD
    Stanford Cancer Institute

  • Robert L. Giuntoli II, MD
    Abramson Cancer Center at the University of Pennsylvania

  • Jayanthi Lea, MD
    UT Southwestern Simmons Comprehensive Cancer Center

  • Mary S. Mably, RPh, BCOP
    University of Wisconsin Carbone Cancer Center

  • Daniel Melzer, PharmD, BCOP
    Moffitt Cancer Center

  • David G. Mutch, MD
    Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

  • Christa I. Nagel, MD
    Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute

  • R. Kevin Reynolds, MD
    University of Michigan Rogel Cancer Center

  • Edward Tanner, MD
    Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Hairy Cell Leukemia

  • Julio C. Chavez, MD
    Moffitt Cancer Center

  • Deborah McCue, PharmD, BCOP
    The University of Texas MD Anderson Cancer Center

  • Samantha Price, PharmD, BCOP
    Moffitt Cancer Center

Head and Neck Cancers

  • Sally Barbour, PharmD, CPP, BCOP, FHOPA
    Duke Cancer Institute

  • Ashish Chintakuntlawar, MD
    Mayo Clinic Cancer Center

  • Kathleen Kerrigan, DO
    Huntsman Cancer Institute at the University of Utah

  • Mary S. Mably, RPh, BCOP
    University of Wisconsin Carbone Cancer Center

  • Eve M. Segal, PharmD, BCOP
    Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

  • John R. Weis, MD
    Huntsman Cancer Institute at the University of Utah

Hepatobiliary Cancers

  • Heidi D. Finnes, PharmD, BCOP
    Mayo Clinic Cancer Center

  • Renuka Iyer, MD
    Roswell Park Comprehensive Cancer Center

  • Robin K. Kelley, MD
    UCSF Helen Diller Family Comprehensive Cancer Center

  • Christopher W. Sherrow, PharmD, BCOP
    Roswell Park Comprehensive Cancer Center

Hodgkin Lymphoma

  • Deborah McCue, PharmD, BCOP
    The University of Texas MD Anderson Cancer Center

  • Michael Styler, MD
    Fox Chase Cancer Center

Kidney Cancer

  • Heidi D. Finnes, PharmD, BCOP
    Mayo Clinic Cancer Center

  • M. Dror Michaelson, MD, PhD
    Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center

  • Shayna A. Simon, PharmD, BCOP
    UT Southwestern Simmons Comprehensive Cancer Center

Malignant Pleural Mesothelioma

  • Courtney C. Cavalieri, PharmD, BCOP
    Huntsman Cancer Institute at the University of Utah

  • Daniel Melzer, PharmD, BCOP
    Moffitt Cancer Center

  • Sandip P. Patel, MD
    UC San Diego Moores Cancer Center

Melanoma: Cutaneous

  • Anthony J. Olszanski, MD, RPh
    Fox Chase Cancer Center

  • John A. Thompson, MD
    Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

  • Lindsey Zinck, MSN, RN, OCN
    Abramson Cancer Center at the University of Pennsylvania

Melanoma: Uveal

  • Heidi D. Finnes, PharmD, BCOP
    Mayo Clinic Cancer Center

  • Kaddie M. Lopez, MSN, RN, OCN, NE-BC
    City of Hope National Medical Center

  • John A. Thompson, MD
    Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

Multiple Myeloma

  • Natalie S. Callander, MD
    University of Wisconsin Carbone Cancer Center

  • Heidi D. Finnes, PharmD, BCOP
    Mayo Clinic Cancer Center

  • Lindsay M. Hladnik, PharmD, BCOP
    Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

  • Leona A. Holmberg, MD, PhD
    Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

  • Yubin Kang, MD
    Duke Cancer Institute

  • Shaji K. Kumar, MD
    Mayo Clinic Cancer Center

  • Kaddie M. Lopez, MSN, RN, OCN, NE-BC
    City of Hope National Medical Center

  • Ila M. Saunders, PharmD, BCOP
    UC San Diego Moores Cancer Center

  • Michael Styler, MD
    Fox Chase Cancer Center

  • Katie Tobon, PharmD, BCOP
    Moffitt Cancer Center

Myelodysplastic Syndromes

  • Mary S. Mably, RPh, BCOP
    University of Wisconsin Carbone Cancer Center

  • James Thompson, MD, MS
    Roswell Park Comprehensive Cancer Center

Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Fusion Genes

  • Allison Balko, PharmD, BCOP
    Vanderbilt-Ingram Cancer Center

  • Elizabeth Hexner, MD
    Abramson Cancer Center at the University of Pennsylvania

  • Lindsay M. Hladnik, PharmD, BCOP
    Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

  • Mary S. Mably, RPh, BCOP
    University of Wisconsin Carbone Cancer Center

  • Deborah McCue, PharmD, BCOP
    The University of Texas MD Anderson Cancer Center

  • Sanjay R. Mohan, MD, MSCI
    Vanderbilt-Ingram Cancer Center

  • James Thompson, MD, MS
    Roswell Park Comprehensive Cancer Center

Myeloproliferative Neoplasms

  • Allison Balko, PharmD, BCOP
    Vanderbilt-Ingram Cancer Center

  • Nikolai Podoltsev, MD, PhD
    Yale Cancer Center/Smilow Cancer Hospital

  • Michael Styler, MD
    Fox Chase Cancer Center

Neuroendocrine and Adrenal Tumors

  • Allison Balko, PharmD, BCOP
    Vanderbilt-Ingram Cancer Center

  • Sally Barbour, PharmD, CPP, BCOP, FHOPA
    Duke Cancer Institute

  • Courtney C. Cavalieri, PharmD, BCOP
    Huntsman Cancer Institute at the University of Utah

  • Heidi D. Finnes, PharmD, BCOP
    Mayo Clinic Cancer Center

  • Daniel Halperin, MD
    The University of Texas MD Anderson Cancer Center

  • Rawmina Keshavarzi, PharmD, BCOP
    Stanford Cancer Institute

  • Kristin Leonardi-Warren, ND, RN, CNS
    University of Colorado Cancer Center

  • Christopher H. Lieu, MD
    University of Colorado Cancer Center

  • Kaddie M. Lopez, MSN, RN, OCN, NE-BC
    City of Hope National Medical Center

  • Mary S. Mably, RPh, BCOP
    University of Wisconsin Carbone Cancer Center

  • Jonathan R. Strosberg, MD
    Moffitt Cancer Center

  • Nataliya Uboha, MD, PhD
    University of Wisconsin Carbone Cancer Center

Non-Small Cell Lung Cancer

  • Sally Barbour, PharmD, CPP, BCOP, FHOPA
    Duke Cancer Institute

  • Courtney C. Cavalieri, PharmD, BCOP
    Huntsman Cancer Institute at the University of Utah

  • Sandip P. Patel, MD
    UC San Diego Moores Cancer Center

  • Aditi P. Singh, MD
    Abramson Cancer Center at the University of Pennsylvania

Occult Primary

  • Sally Barbour, PharmD, CPP, BCOP, FHOPA
    Duke Cancer Institute

  • Courtney C. Cavalieri, PharmD, BCOP
    Huntsman Cancer Institute at the University of Utah

  • Keith D. Eaton, MD, PhD
    Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

  • Mary S. Mably, RPh, BCOP
    University of Wisconsin Carbone Cancer Center

  • Eve M. Segal, PharmD, BCOP
    Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

  • Marvaretta M. Stevenson, MD
    Duke Cancer Institute

Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer

  • Sally Barbour, PharmD, CPP, BCOP, FHOPA
    Duke Cancer Institute

  • Lainie Martin, MD
    Abramson Cancer Center at the University of Pennsylvania

  • Theresa L. Werner, MD
    Huntsman Cancer Institute at the University of Utah

  • Lindsey Zinck, MSN, RN, OCN
    Abramson Cancer Center at the University of Pennsylvania

Pancreatic Adenocarcinoma

  • E. Gabriela Chiorean, MD
    Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

  • Rawmina Keshavarzi, PharmD, BCOP
    Stanford Cancer Institute

Primary Cutaneous Lymphomas

  • Martina Fraga, PharmD
    University of Michigan Rogel Cancer Center

  • Gaurav Goyal, MD
    O'Neal Comprehensive Cancer Center at UAB

  • Bradley M. Haverkos, MD, MPH, MS
    University of Colorado Cancer Center

  • Mitchell E. Hughes, PharmD, BCOP
    Abramson Cancer Center at the University of Pennsylvania

  • Deepa Jagadeesh, MD, MPH
    Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute

  • Allison V. Jones, MD, FAAD
    St. Jude Children's Research Hospital/The University of Tennessee Health Science Center

  • Kaddie M. Lopez, MSN, RN, OCN, NE-BC
    City of Hope National Medical Center

  • Deborah McCue, PharmD, BCOP
    The University of Texas MD Anderson Cancer Center

  • Elise A. Olsen, MD
    Duke Cancer Institute

  • Ila M. Saunders, PharmD, BCOP
    UC San Diego Moores Cancer Center

  • Katie Tobon, PharmD, BCOP
    Moffitt Cancer Center

Prostate Cancer

  • Andrew J. Armstrong, MD, ScM
    Duke Cancer Institute

  • Allison Balko, PharmD, BCOP
    Vanderbilt-Ingram Cancer Center

Rectal Cancer

  • Sally Barbour, PharmD, CPP, BCOP, FHOPA
    Duke Cancer Institute

  • Alan Chin, PharmD, BCOP
    UCSF Helen Diller Family Comprehensive Cancer Center

  • Stacey A. Cohen, MD
    Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

Small Bowel Adenocarcinoma

  • Sally Barbour, PharmD, CPP, BCOP, FHOPA
    Duke Cancer Institute

  • Courtney C. Cavalieri, PharmD, BCOP
    Huntsman Cancer Institute at the University of Utah

  • Rawmina Keshavarzi, PharmD, BCOP
    Stanford Cancer Institute

  • Mary S. Mably, RPh, BCOP
    University of Wisconsin Carbone Cancer Center

  • Michael Overman, MD
    The University of Texas MD Anderson Cancer Center

  • Eve M. Segal, PharmD, BCOP
    Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

  • Audrea H. Szabatura, PharmD, BCOP
    Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center

  • Lindsey Zinck, MSN, RN, OCN
    Abramson Cancer Center at the University of Pennsylvania

Small Cell Lung Cancer

  • Sally Barbour, PharmD, CPP, BCOP, FHOPA
    Duke Cancer Institute

  • Rafael Santana-Davila, MD
    Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

Soft Tissue Sarcoma

  • Edwin Choy, MD, PhD
    Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center

  • Kristen N. Ganjoo, MD
    Stanford Cancer Institute

  • Daniel Melzer, PharmD, BCOP
    Moffitt Cancer Center

Systemic Light Chain Amyloidosis

  • Martina Fraga, PharmD
    University of Michigan Rogel Cancer Center

  • Carol Ann Huff, MD
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

  • Yubin Kang, MD
    Duke Cancer Institute

  • Mary S. Mably, RPh, BCOP
    University of Wisconsin Carbone Cancer Center

  • Deborah McCue, PharmD, BCOP
    The University of Texas MD Anderson Cancer Center

  • Michael Styler, MD
    Fox Chase Cancer Center

Systemic Mastocytosis

  • Aaron T. Gerds, MD, MS
    Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute

  • Deborah McCue, PharmD, BCOP
    The University of Texas MD Anderson Cancer Center

T-Cell Lymphomas

  • Gaurav Goyal, MD
    O'Neal Comprehensive Cancer Center at UAB

  • Ashley M. Kenkel, PharmD, BCOP
    Fred & Pamela Buffett Cancer Center

  • Deborah McCue, PharmD, BCOP
    The University of Texas MD Anderson Cancer Center

Testicular Cancer

  • Joel Picus, MD
    Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

Thymomas and Thymic Carcinomas

  • Sally Barbour, PharmD, CPP, BCOP, FHOPA
    Duke Cancer Institute

  • Daniel Melzer, PharmD, BCOP
    Moffitt Cancer Center

  • Sandip P. Patel, MD
    UC San Diego Moores Cancer Center

Thyroid Carcinoma

  • Sally Barbour, PharmD, CPP, BCOP, FHOPA
    Duke Cancer Institute

  • Kristin Leonardi-Warren, ND, RN, CNS
    University of Colorado Cancer Center

  • Daniel Melzer, PharmD, BCOP
    Moffitt Cancer Center

  • Eric J. Sherman, MD
    Memorial Sloan Kettering Cancer Center

  • Lori J. Wirth, MD
    Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center

Uterine Neoplasms

  • Marta Ann Crispens, MD
    Vanderbilt-Ingram Cancer Center

Vulvar Cancer

  • Nadeem R. Abu-Rustum, MD
    Memorial Sloan Kettering Cancer Center

  • Marta Ann Crispens, MD
    Vanderbilt-Ingram Cancer Center

Waldenström Macroglobulinemia / Lymphoplasmacytic Lymphoma

  • Carol Ann Huff, MD
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

  • Yubin Kang, MD
    Duke Cancer Institute

  • Mary S. Mably, RPh, BCOP
    University of Wisconsin Carbone Cancer Center